Isn't that what everyone wanted to hear which is after 3 weeks of investigation the company feels it is worth continuing the investigation at any cost rather than throwing in the towel?. Isn't today's PR concentrates on getting Takeda to pay e bigger share of the investigation. Isn't even the reason given for laying off 75% of the staff is to CONSERVE funds for continuing the investigation to a positive conclusion and returning the drug to the market??
Would the company go so far stressing the importance of continuing with the investigation and try so hard to push Takeda to put more money into it (by even threatening BK) if they thought Omontys was not good?
Folks wake up. Today's PR was actually positive in terms of the company having concluded that after 3 weeks of looking into the issues that the investigation must go on at any cost. That tells me that they think Omontys will, at the end of such investigation, return to market.
I read the PR statement over and over and I definitely agree with you. Sure some measures have been undertaken to preserve funds but the basic investigation and belief in Omontys continues.
It would be funny if you turned out to be right and shares actually close green today. That may be a possibility actually only if traders begin to see the pr as what it really is trying to say.
I agree 100%. The AH pps drop is been a knee jerk reaction from seeing the word BK. But the reality is that I agree that was just a term used to pressure their Japanese partner to put up more funds for the investigation.
But like you I agree that the jest of today's PR was to say that the investigation so far have convinced them that it should continue and that the outcome will be worth such continuation. To me that is a big positive news. Three weeks of investigation and their only worry right now is funding for the investigation. There isn't any hint that such investigation may be a waste. To the contrary they seem to say they like it to continue "until FDA approval".
It seems to me the PR clearly shows they confidant about the future of the drug and their only concern and reason behind today's release is having the funding to bring it back